ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 119 filers reported holding ANAPTYSBIO INC in Q4 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,324,292 | -44.8% | 252,366 | -50.4% | 0.06% | -42.9% |
| Q1 2024 | $11,459,054 | -55.2% | 508,839 | -57.4% | 0.10% | -62.2% |
| Q4 2023 | $25,596,343 | +69.5% | 1,194,974 | +42.1% | 0.28% | +57.1% |
| Q3 2023 | $15,101,145 | -28.2% | 840,821 | -18.7% | 0.18% | -28.9% |
| Q2 2023 | $21,042,727 | +110.4% | 1,034,549 | +125.1% | 0.25% | +83.1% |
| Q1 2023 | $10,000,069 | -50.2% | 459,562 | -29.0% | 0.14% | -49.3% |
| Q4 2022 | $20,067,420 | -29.1% | 647,545 | -41.7% | 0.27% | -32.3% |
| Q3 2022 | $28,320,000 | +51.5% | 1,110,162 | +20.6% | 0.40% | +37.5% |
| Q2 2022 | $18,689,000 | -9.4% | 920,638 | +10.4% | 0.29% | -14.0% |
| Q1 2022 | $20,631,000 | -2.7% | 833,927 | +36.7% | 0.34% | +10.2% |
| Q4 2021 | $21,197,000 | -22.9% | 609,981 | -39.8% | 0.30% | -32.3% |
| Q3 2021 | $27,498,000 | +96.4% | 1,013,956 | +87.8% | 0.45% | +72.0% |
| Q2 2021 | $14,004,000 | +51.5% | 540,052 | +25.9% | 0.26% | +27.3% |
| Q1 2021 | $9,242,000 | – | 428,847 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $91,347,000 | 18.37% |
| EcoR1 Capital, LLC | 7,521,024 | $261,356,000 | 8.33% |
| GREAT POINT PARTNERS LLC | 592,250 | $20,581,000 | 4.57% |
| FRAZIER MANAGEMENT LLC | 899,700 | $31,265,000 | 2.41% |
| Boxer Capital, LLC | 1,300,000 | $45,175,000 | 1.76% |
| Palo Alto Investors LP | 436,592 | $15,172,000 | 0.97% |
| Rock Springs Capital Management LP | 538,700 | $18,720,000 | 0.43% |
| Eversept Partners, LP | 182,612 | $6,345,767 | 0.40% |
| EAM Global Investors LLC | 58,683 | $2,039,000 | 0.36% |
| Woodline Partners LP | 609,981 | $21,197,000 | 0.30% |